The stock of P3 Health Partners Inc. (NASDAQ:PIII) decreased by $0.0 on Tuesday to finish at $1.68, down 0.00 percent. The last five days have seen an average of 1,568,720 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$0.1600. The average number of shares traded over the last 20 days was 874,465, while the average volume over the last 50 days totaled 495,938.
PIII stock appreciated 1.20% since last month. On 08/25/23, the company’s shares reached a one-month low of $1.3050. The stock touched a high of $6.54 on 06/06/23, after rallying from a low of $0.70 in 52 weeks. The price of PIII stock has declined by -8.70% or -$0.1600 this year, reaching a new high 9 times. Still, the stock price is down -74.31% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
PIII stock investors should be aware that P3 Health Partners Inc. (PIII) stock had its last reported insider trading activity 7 days ago on Sep 13. On Sep 13, 10% Owner Chicago Pacific Founders UGP I acquired 90,000 shares at $2.65 each. This transaction resulted in the insider spending $238,221. On Sep 12, Chicago Pacific Founders UGP I added 90,000 shares at a price of US$2.63. After the transaction, the insider now owns 49,935,442 shares. 10% Owner Chicago Pacific Founders UGP I had earlier bought 90,000 shares on Sep 11 for $2.52 a share. The transaction was completed for $227,142.
Financial Health
For the three months ended June 29, P3 Health Partners Inc.’s quick ratio was 0.70, while its current ratio was 0.70, indicating its inability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 2.30% percent. P3 Health Partners Inc.’s EBITDA margin for the year ended June 29 was -15.12%, whereas its operating margin stood at -58.60% for the same period. Based on annual data, it had gross profit of -$7.75 million and revenue of $1.05 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PIII’s return on assets (ROA) during the last 12 months has been -12.30%. In the meantime, the return on equity (ROE) for the last 12 months was 904.70%.
Earnings Surprise
According to P3 Health Partners Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $329.09 million, while revenues rose by 18.12% to $302.08 million. It was predicted that P3 Health Partners Inc.’s quarterly earnings would be -$0.09, but it ended up being -$0.13, beating the consensus by 30.80%. EBITDA was $0.81 million for the quarter. At the end of P3 Health Partners Inc.’s most recent quarter ended June 29, its liabilities totaled 1.05 billion, while its total debt was $119.98 million. Equity owned by shareholders amounts to $312.68 million.
Technical Picture
Here’s a quick look at P3 Health Partners Inc.’s (PIII) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 37.56%, suggesting the stock is Neutral, with a 185.98% historical volatility rate.
The stochastic %K and %D were 22.63% and 42.61% respectively, while the average true range (ATR) was 0.3145. Based on the 14-day stochastic reading of 8.04%, the RSI (14) reading is 40.98%. On the 9-day MACD Oscillator, the stock is at -0.3767, and the 14-day reading is at -0.3207.
Analyst Ratings
In its analyst report released on September 01, 2023, BTIG Research began covering P3 Health Partners Inc. (NASDAQ: PIII). The stock was rated as a Buy by the brokerage firm. Analysts have assigned P3 Health Partners Inc. (PIII) an Buy rating. PIII is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is PIII’s price target for the next 12 months?
The current consensus forecast for the stock is between $3.50 and $9.00, with a median target price of $4.50. In analyzing these forecasts, the average price target given by analysts for P3 Health Partners Inc. (PIII) is $5.38.
